基于诺哈曼的四元化小分子抗菌模仿剂的合成和抗MRSA活性
Wenjia Dan1, Yingyan Xiong1, Runchu Li1
1School of Life Science and Technology, Shandong Second Medical University, Weifang, Shandong, China.
European journal of medicinal chemistry
|March 19, 2025
概括
一种新型的小分子抗微生物模仿剂 (SMAPM) 显示出对抗抗甲素耐药黄金葡萄球菌 (MRSA) 的强有力的活性. 这种化合物有效地治疗小鼠MRSA皮肤感染,具有多目标机制和良好的安全性.
科学领域:
- 药用化学 医学化学
- 发现抗微生物药物 发现抗微生物药物
- 分子药理学分子药理学
背景情况:
- 梅西林耐药黄金葡萄球菌 (MRSA) 感染的流行率不断上升.
- 当前抗生素的有效性下降,需要新的治疗策略.
研究的目的:
- 开发针对MRSA的新型抗菌剂.
- 研究小分子抗微生物模仿剂 (SMAPMs) 的疗效和作用机制.
主要方法:
- 基于诺哈曼骨架的四元化SMAPM的合成.
- 在体外抗菌活性测试 (MIC确定).
- 在小鼠皮肤感染模型中的体内疗效评估.
- 机理学研究包括生物膜抑制,细胞壁和膜向,代谢活性,氧化还原稳定和DNA结合测试.
主要成果:
- 化合物10c是一种新型SMAPM,在体外对MRSA表现出强烈的活性 (MIC = 0.25μg/mL).
- 化合物10c在体内表现出显著的治疗疗效,并具有快速杀菌的特性.
- 该化合物具有较低的抗性诱导倾向,良好的血稳定性和可接受的生物安全性.
- 机理学研究显示了多目标作用,包括生物膜抑制,细胞壁/膜破坏,代谢干扰和DNA结合.
结论:
- 化合物10c是抗MRSA药物开发的有希望的候选者.
- 该SMAPMs战略为设计针对耐药病原体的新型抗菌疗法提供了一个有价值的平台.
更多相关视频
03:29Author Spotlight: Advancing Therapeutics to Treat Vibriosis in Humans and Aquatic Organisms
Published on: May 31, 2024
373
12:02An Efficient Method for the Synthesis of Peptoids with Mixed Lysine-type/Arginine-type Monomers and Evaluation of Their Anti-leishmanial Activity
Published on: November 2, 2016
12.0K
相关概念视频
Antimicrobial Proteins
849
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
849
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
